We are live on ! Find out more
RDHL

Redhill Biopharma

52 hedge funds and large institutions have $65M invested in Redhill Biopharma in 2020 Q4 according to their latest regulatory filings, with 11 funds opening new positions, 19 increasing their positions, 11 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

83% more first-time investments, than exits

New positions opened: 11 | Existing positions closed: 6

73% more repeat investments, than reductions

Existing positions increased: 19 | Existing positions reduced: 11

11% more funds holding

Funds holding: 4752 (+5)

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

0% more ownership

Funds ownership: 0%0% (+0%)

2% less call options, than puts

Call options by funds: $2.2M | Put options by funds: $2.26M

16% less capital invested

Capital invested by funds: $77.5M → $65M (-$12.6M)

Holders
52
Holders Change
+5
Holders Change %
+10.64%
% of All Funds
0.92%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.02%
New
11
Increased
19
Reduced
11
Closed
6
Calls
$2.2M
Puts
$2.26M
Net Calls
-$54K
Net Calls Change
-$19K

RDHL Hedge Fund Activity: Q4 2020 in Review

52 of the 5,651 institutional investors tracked by Wall St. Rank reported a position in Redhill Biopharma (RDHL) for Q4 2020, worth a combined $65M — down 16% from $77.5M a quarter earlier.

Buyers outnumbered sellers: 11 funds opened new RDHL positions and 6 closed out — a net gain of 5 holders — while 19 added to existing stakes and 11 trimmed.

The largest buyer was BlackRock, opening a new position worth an estimated $2.99M. The largest seller was Schonfeld Strategic Advisors, cutting an estimated $1.19M.

  • 52 institutional investors held Redhill Biopharma (RDHL) as of Q4 2020, up from 47 in Q3 2020.
  • Funds reported $65M of Redhill Biopharma stock for Q4 2020, down 16% quarter-over-quarter.
  • 11 funds opened new Redhill Biopharma positions in Q4 2020 and 6 closed out, a net change of +5 holders.
  • The largest Redhill Biopharma buyer in Q4 2020 was BlackRock, an estimated $2.99M added.
  • The largest Redhill Biopharma seller in Q4 2020 was Schonfeld Strategic Advisors, an estimated $1.19M sold.

Based on aggregated 13F filings for Q4 2020.